These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15317754)

  • 1. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy.
    O'Cochlain DF; Perez-Terzic C; Reyes S; Kane GC; Behfar A; Hodgson DM; Strommen JA; Liu XK; van den Broek W; Wansink DG; Wieringa B; Terzic A
    Hum Mol Genet; 2004 Oct; 13(20):2505-18. PubMed ID: 15317754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy.
    Mahadevan MS; Yadava RS; Yu Q; Balijepalli S; Frenzel-McCardell CD; Bourne TD; Phillips LH
    Nat Genet; 2006 Sep; 38(9):1066-70. PubMed ID: 16878132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy.
    Reddy S; Smith DB; Rich MM; Leferovich JM; Reilly P; Davis BM; Tran K; Rayburn H; Bronson R; Cros D; Balice-Gordon RJ; Housman D
    Nat Genet; 1996 Jul; 13(3):325-35. PubMed ID: 8673132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties.
    Groenen PJ; Wansink DG; Coerwinkel M; van den Broek W; Jansen G; Wieringa B
    Hum Mol Genet; 2000 Mar; 9(4):605-16. PubMed ID: 10699184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy.
    Klesert TR; Cho DH; Clark JI; Maylie J; Adelman J; Snider L; Yuen EC; Soriano P; Tapscott SJ
    Nat Genet; 2000 May; 25(1):105-9. PubMed ID: 10802667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1.
    Ait Benichou S; Jauvin D; De Serres-Bérard T; Bennett F; Rigo F; Gourdon G; Boutjdir M; Chahine M; Puymirat J
    Hum Gene Ther; 2022 Aug; 33(15-16):810-820. PubMed ID: 35794764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
    Kaliman P; Llagostera E
    Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase.
    Mounsey JP; Mistry DJ; Ai CW; Reddy S; Moorman JR
    Hum Mol Genet; 2000 Sep; 9(15):2313-20. PubMed ID: 11001935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of age and gene dose on skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase.
    Reddy S; Mistry DJ; Wang QC; Geddis LM; Kutchai HC; Moorman JR; Mounsey JP
    Muscle Nerve; 2002 Jun; 25(6):850-7. PubMed ID: 12115974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy.
    Ueda H; Shimokawa M; Yamamoto M; Kameda N; Mizusawa H; Baba T; Terada N; Fujii Y; Ohno S; Ishiura S; Kobayashi T
    J Neurol Sci; 1999 Jan; 162(1):38-50. PubMed ID: 10064167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy in congenital myotonic dystrophy.
    Igarashi H; Momoi MY; Yamagata T; Shiraishi H; Eguchi I
    Pediatr Neurol; 1998 Apr; 18(4):366-9. PubMed ID: 9588538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase.
    Lee HC; Patel MK; Mistry DJ; Wang Q; Reddy S; Moorman JR; Mounsey JP
    Physiol Genomics; 2003 Jan; 12(2):147-57. PubMed ID: 12454205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice.
    Jansen G; Groenen PJ; Bächner D; Jap PH; Coerwinkel M; Oerlemans F; van den Broek W; Gohlsch B; Pette D; Plomp JJ; Molenaar PC; Nederhoff MG; van Echteld CJ; Dekker M; Berns A; Hameister H; Wieringa B
    Nat Genet; 1996 Jul; 13(3):316-24. PubMed ID: 8673131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dmpk gene deletion or antisense knockdown does not compromise cardiac or skeletal muscle function in mice.
    Carrell ST; Carrell EM; Auerbach D; Pandey SK; Bennett CF; Dirksen RT; Thornton CA
    Hum Mol Genet; 2016 Oct; 25(19):4328-4338. PubMed ID: 27522499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive atrioventricular conduction block in a mouse myotonic dystrophy model.
    Berul CI; Maguire CT; Gehrmann J; Reddy S
    J Interv Card Electrophysiol; 2000 Jun; 4(2):351-8. PubMed ID: 10936001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model.
    Berul CI; Maguire CT; Aronovitz MJ; Greenwood J; Miller C; Gehrmann J; Housman D; Mendelsohn ME; Reddy S
    J Clin Invest; 1999 Feb; 103(4):R1-7. PubMed ID: 10021468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of intracellular signaling pathways that induce myotonic dystrophy protein kinase expression during myogenesis.
    Carrasco M; Canicio J; Palacín M; Zorzano A; Kaliman P
    Endocrinology; 2002 Aug; 143(8):3017-25. PubMed ID: 12130568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1.
    Pandey SK; Wheeler TM; Justice SL; Kim A; Younis HS; Gattis D; Jauvin D; Puymirat J; Swayze EE; Freier SM; Bennett CF; Thornton CA; MacLeod AR
    J Pharmacol Exp Ther; 2015 Nov; 355(2):329-40. PubMed ID: 26330536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action.
    Llagostera E; Catalucci D; Marti L; Liesa M; Camps M; Ciaraldi TP; Kondo R; Reddy S; Dillmann WH; Palacin M; Zorzano A; Ruiz-Lozano P; Gomis R; Kaliman P
    PLoS One; 2007 Nov; 2(11):e1134. PubMed ID: 17987120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.